Used as an intermediate in the synthesis of olmesartan medoxomil, a prodrug for the treatment of hypertension. It plays a key role in protecting the imidazole nitrogen during the manufacturing process, allowing selective chemical modifications. The trityl group is later removed under acidic conditions to reveal the active pharmaceutical ingredient. This compound is essential in improving yield and purity during large-scale production of the antihypertensive drug.